Conference
Cardiovascular protection: a breakthrough for high-risk patients
Abstract
Blockade of the renin–angiotensin system (RAS) with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ARBs) has been shown to reduce cardiovascular mortality and morbidity in various patient populations. The recent ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) and Telmisartan Randomized AssessmeNt Study in aCE iNtolerant subjects with cardiovascular Disease (TRANSCEND) …
Authors
Böhm M; Mahfoud F; Werner C; Teo K; Baumhäkel M
Volume
11
Pagination
pp. f19-f26
Publisher
Oxford University Press (OUP)
Publication Date
December 1, 2009
DOI
10.1093/eurheartj/sup024
Conference proceedings
European Heart Journal Supplements
Issue
suppl_F
ISSN
1520-765X